Do Flavors Increase the Addiction Potential of Nicotine?
NCT ID: NCT04696380
Last Updated: 2022-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
19 participants
INTERVENTIONAL
2021-03-01
2021-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our major hypothesis is that the pharmacological effect of nicotine to induce addiction will be greater with use of a preferred e-cigarette flavor than with use of a non-preferred flavor. The pharmacological effect will be measured by how much a larger nicotine dose increases addiction potential compared to a smaller dose.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Establishing the Effect of Flavor on the Addictive Potential of Electronic Cigarettes
NCT03905928
Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 1
NCT02179034
The Effects of Menthol as Delivered by an Electronic Cigarette on the Desirability of Nicotine in Tobacco Users
NCT02102100
Effects of Menthol in E-cigarettes on Smoking Behaviors
NCT04521647
Impact of Flavors on Nicotine Perception and Self-Administration Via E-cigarettes
NCT04038515
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Fifteen participants who currently use e-cigarettes weekly and who use or do not use tobacco cigarettes will enter a remote session study. Participants will be asked to abstain from all nicotine/tobacco products, non-nicotine electronic cigarettes, and THC containing products for 16 hours prior to four experimental sessions and will be tested in a 2x2 within-participants design with four conditions: 1) low nicotine dose (3%)/non-preferred flavor, 2) low dose/preferred flavor, 3) high dose (5%)/non-preferred flavor, and 4) high dose/preferred flavor. Order of testing will be randomized. Participants and experimenters will be blind to dose. The major outcomes will be subjective effects, e.g. liking and tests of reinforcement (choice procedures). We will require 16 hours of abstinence prior to each remote experimental session to increase the sensitivity to nicotine effects.
The consent process, experimental sessions and data collection will all be done remotely using a secure video platform. The only interaction between participants and research staff will be the curbside pick-up of study products, which will follow social distancing and mask guidelines. Participants will pick up study JUUL pods curb-side at the University of Vermont before their baseline videoconference session. Participants will be required to conduct all videoconference sessions in a place where they can legally use their JUUL.
The consent videoconference session will be conducted prior to the baseline and four experimental sessions. Participants will be assessed for COVID-19 and E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI) symptoms prior to the curbside pick-up and at the start of the 5 videoconference sessions in which they will be asked to vape. During the baseline session, participants will complete a baseline questionnaire via online survey and then answer a series of questions about nicotine dependence and how many JUUL pods they would purchase at varying prices. Participants will then sample the two flavors available for JUUL -Virginia Tobacco and Menthol- using their own JUUL device. Research staff will ask participants to rate the pleasantness of each flavor and, after they have tried the flavors, participants will rank order their flavor preferences to determine their preferred flavor of the two. Finally, participants will be trained in the puffing protocol to be used in the experimental sessions.
During each experimental videoconference session, participants will report on their recent e-cigarette and tobacco product use at the start of each videoconference testing session. Those reporting non-abstinence will have their videoconference session rescheduled. During the videoconference testing sessions participants will be asked to puff either tobacco flavor 3% nicotine, tobacco flavor 5% nicotine, menthol flavor 3% nicotine, or menthol flavor 5% nicotine. After each puffing bout within each session, they will answer questions about about e-cigarette effects, e-cigarette liking and wanting, like/dislike of e-cigarette taste and e-cigarette intensity. At the end of each session, they will be asked how many JUUL pods they would purchase at varying prices.
Adverse events will be collected at the end of each videoconference session by the research assistant, who will consult with the study licensed medical provider.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High nicotine, preferred flavor
Participants will sample their preferred flavored JUUL e-cigarette at 5% nicotine strength.
Nicotine
Participants will sample high vs low nicotine.
JUUL e-cigarette
Participants will sample preferred vs non-preferred JUUL flavors.
High nicotine, non-preferred flavor
Participants will sample their non-preferred flavored JUUL e-cigarette at 5% nicotine strength.
Nicotine
Participants will sample high vs low nicotine.
JUUL e-cigarette
Participants will sample preferred vs non-preferred JUUL flavors.
Low nicotine, preferred flavor
Participants will sample their preferred flavored JUUL e-cigarette at 3% nicotine strength.
Nicotine
Participants will sample high vs low nicotine.
JUUL e-cigarette
Participants will sample preferred vs non-preferred JUUL flavors.
Low nicotine, non-preferred flavor
Participants will sample their non-preferred flavored JUUL e-cigarette at 3% nicotine strength.
Nicotine
Participants will sample high vs low nicotine.
JUUL e-cigarette
Participants will sample preferred vs non-preferred JUUL flavors.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nicotine
Participants will sample high vs low nicotine.
JUUL e-cigarette
Participants will sample preferred vs non-preferred JUUL flavors.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* comfortable reading and writing English
* own a JUUL brand e-cigarette they have used at least 10 times in the past 30 days
* use JUUL e-cigarettes and JUUL pods with 5% nicotine
* used e-cigarettes on 4+ days a week in the last 30 days
* use or do not use tobacco cigarettes
* do not plan to quit e-cigarettes in the next 30 days
* non-pregnant females verified by pregnancy test
* access to the internet in a location where they could join a videoconference call and legally use their JUUL.
* Reside in VT
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Vermont
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
John Hughes, MD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John R Hughes, MD
Role: PRINCIPAL_INVESTIGATOR
University of Vermont
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Vermont
Burlington, Vermont, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Peasley-Miklus C, Klemperer EM, Hughes JR, Villanti AC, Krishnan-Sarin S, DeSarno MJ, Mosca LA, Su A, Cassidy RN, Feinstein MJP. The interactive effects of JUUL flavor and nicotine concentration on addiction potential. Exp Clin Psychopharmacol. 2023 Apr;31(2):336-342. doi: 10.1037/pha0000591. Epub 2022 Sep 1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHRMS 00000555
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.